UY37082A - Anticuerpos monoclonales específicos para el antígeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por adv - Google Patents
Anticuerpos monoclonales específicos para el antígeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por advInfo
- Publication number
- UY37082A UY37082A UY0001037082A UY37082A UY37082A UY 37082 A UY37082 A UY 37082A UY 0001037082 A UY0001037082 A UY 0001037082A UY 37082 A UY37082 A UY 37082A UY 37082 A UY37082 A UY 37082A
- Authority
- UY
- Uruguay
- Prior art keywords
- adv
- useful
- monoclonal antibodies
- piii
- hybridomes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La presente invención se refiere a anticuerpos monoclonales, o fragmentos de los mismos, que reconocen la proteína pIII del Adenovirus (ADV), útiles para el desarrollo de métodos de diagnóstico de infección por ADV en humanos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CL2016000164A CL2016000164A1 (es) | 2016-01-21 | 2016-01-21 | Anticuerpos monoclonales específicos para el antígeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por adv. |
Publications (1)
Publication Number | Publication Date |
---|---|
UY37082A true UY37082A (es) | 2017-04-28 |
Family
ID=56610130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001037082A UY37082A (es) | 2016-01-21 | 2017-01-20 | Anticuerpos monoclonales específicos para el antígeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por adv |
Country Status (14)
Country | Link |
---|---|
US (1) | US10766948B2 (es) |
EP (2) | EP3406262B1 (es) |
CN (1) | CN108697796B (es) |
AR (1) | AR107440A1 (es) |
BR (1) | BR112018014538A2 (es) |
CA (1) | CA3011569A1 (es) |
CL (1) | CL2016000164A1 (es) |
ES (1) | ES2898068T3 (es) |
MX (1) | MX2018008809A (es) |
PE (1) | PE20181498A1 (es) |
PT (1) | PT3406262T (es) |
UY (1) | UY37082A (es) |
WO (1) | WO2017125892A2 (es) |
ZA (1) | ZA201804705B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CL2018003869A1 (es) * | 2018-12-28 | 2021-01-15 | Univ Pontificia Catolica Chile | Anticuerpos monoclonales específicos para la proteína quimérica l del virus de la parainfluenza humana (piv), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por piv |
CN113354727B (zh) * | 2021-08-10 | 2021-11-02 | 北京溯本源和生物科技有限公司 | 一组同时检测b/c/e组腺病毒的单克隆抗体和试纸条 |
CN116789807B (zh) * | 2023-06-14 | 2024-01-16 | 珠海重链生物科技有限公司 | 抗腺病毒单克隆抗体及其应用 |
CN117586385B (zh) * | 2023-11-23 | 2024-05-17 | 广州医科大学附属第一医院(广州呼吸中心) | 抗人4型腺病毒中和抗体及其制备方法和应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4487829A (en) | 1982-03-23 | 1984-12-11 | Massachusetts Institute Of Technology | Production and use of monoclonal antibodies against adenoviruses |
US6248514B1 (en) | 1996-07-09 | 2001-06-19 | Canji, Inc. | Methods for measuring viral infectivity |
EP0967484B1 (en) | 1997-08-04 | 2007-05-02 | Advanced Life Science Institute, Inc. | Methods for detecting or assaying virus |
IL153853A0 (en) * | 2000-07-10 | 2003-07-31 | Novartis Ag | Bifunctional molecules and vectors complexed therewith for targeted gene delivery |
WO2005023848A2 (en) * | 2003-09-09 | 2005-03-17 | Gardner, Rebecca, Katherine | Adenoviral epitopes |
WO2005054469A1 (en) * | 2003-12-05 | 2005-06-16 | Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health | Anti-sars monoclonal antibodies |
US8003108B2 (en) | 2005-05-03 | 2011-08-23 | Amgen Inc. | Sclerostin epitopes |
EP2529754A1 (en) * | 2007-05-03 | 2012-12-05 | Agency For Science, Technology And Research (A*star) | Antibodies binding to an intracellular PRL-1 or PRL-3 polypeptide |
-
2016
- 2016-01-21 CL CL2016000164A patent/CL2016000164A1/es unknown
-
2017
- 2017-01-20 CN CN201780007470.2A patent/CN108697796B/zh active Active
- 2017-01-20 WO PCT/IB2017/050312 patent/WO2017125892A2/es active Application Filing
- 2017-01-20 ES ES17741167T patent/ES2898068T3/es active Active
- 2017-01-20 PE PE2018001294A patent/PE20181498A1/es unknown
- 2017-01-20 AR ARP170100158A patent/AR107440A1/es unknown
- 2017-01-20 US US16/070,730 patent/US10766948B2/en active Active
- 2017-01-20 EP EP17741167.5A patent/EP3406262B1/en active Active
- 2017-01-20 CA CA3011569A patent/CA3011569A1/en active Pending
- 2017-01-20 UY UY0001037082A patent/UY37082A/es not_active Application Discontinuation
- 2017-01-20 PT PT177411675T patent/PT3406262T/pt unknown
- 2017-01-20 MX MX2018008809A patent/MX2018008809A/es unknown
- 2017-01-20 BR BR112018014538-6A patent/BR112018014538A2/pt unknown
- 2017-01-20 EP EP20166433.1A patent/EP3756685A1/en active Pending
-
2018
- 2018-07-13 ZA ZA2018/04705A patent/ZA201804705B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CL2016000164A1 (es) | 2016-07-29 |
WO2017125892A2 (es) | 2017-07-27 |
MX2018008809A (es) | 2018-11-29 |
CN108697796B (zh) | 2023-01-10 |
EP3406262A2 (en) | 2018-11-28 |
PT3406262T (pt) | 2021-11-03 |
CA3011569A1 (en) | 2017-07-27 |
US20190048065A1 (en) | 2019-02-14 |
AR107440A1 (es) | 2018-05-02 |
EP3406262A4 (en) | 2019-01-09 |
PE20181498A1 (es) | 2018-09-18 |
EP3756685A1 (en) | 2020-12-30 |
ZA201804705B (en) | 2019-09-25 |
US10766948B2 (en) | 2020-09-08 |
WO2017125892A3 (es) | 2018-04-12 |
EP3406262B1 (en) | 2021-07-28 |
CN108697796A (zh) | 2018-10-23 |
ES2898068T3 (es) | 2022-03-03 |
BR112018014538A2 (pt) | 2018-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2022003769A1 (es) | Anticuerpos de unión a cd3 | |
BR112018067522A2 (pt) | anticorpos específicos para receptor de poliovírus humano (pvr) | |
CL2019000067A1 (es) | Anticuerpos nuevos que se unen específicamente a los epítopos del virus del zika y usos de los mismos. | |
CU20160101A7 (es) | Inmunoglobulina con fab en tándem | |
BR112018074453A2 (pt) | proteínas de ligação biespecíficas ligando uma protéina imunomoduladora e um antígeno tumoral | |
CO2017012974A2 (es) | Anticuerpos de unión a tau | |
EA201890285A1 (ru) | Антитела против pd-1, активируемые антитела против pd-1 и способы их применения | |
CR20170059A (es) | ANTICUERPOS Anti-LAG3 Y FRAGMENTOS DE UNIÓN A ANTÍGENO | |
BR112018016226A2 (pt) | anticorpo antilipoarabinomanana (anti-lam) monoclonal humano, anticorpos anti-lam monoclonal humano, anticorpo anti-pim6/lam monoclonal humano, kit para detectar pelo menos um epítopo de lam, método para diagnosticar uma infecção de tuberculose ativa em um indivíduo, e método para tratar uma infecção de tuberculose em um indivíduo | |
EA201692394A1 (ru) | Антитела и антигенсвязывающие фрагменты, которые специфично связываются с белком тау, ассоциированным с микротрубочками | |
PE20210650A1 (es) | Terapia basada en anticuerpos de amiloidosis por transtiretina (ttr) y anticuerpos derivados de humanos de la misma | |
EA201991005A1 (ru) | Антитела и полипептиды, направленные против cd127 | |
CO2017012971A2 (es) | Anticuerpos de unión a tau | |
EA201591973A1 (ru) | Антитела человека, связывающиеся с g-белком rsv | |
UY37082A (es) | Anticuerpos monoclonales específicos para el antígeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por adv | |
MX2020004674A (es) | Anticuerpos contra alfa-sinucleina y usos de los mismos. | |
CO2018012497A2 (es) | Anticuerpos de interferón beta y usos de los mismos | |
CL2015002152A1 (es) | Anticuerpos monoclonales específicos para el antígeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnostico de la infección causada por vrsh | |
BR112020015498A8 (pt) | Anticorpos anti-pd-1 | |
CO2019002550A2 (es) | Anticuerpos anti-gm-csf y usos de los mismos | |
EA201992317A1 (ru) | Композиции и способы для диагностики рака легких | |
CR20190086A (es) | Anticuerpo o un fragmento de union a antígeno del mismo, capaz de unirsea un receptor humano de interleucina-6 | |
MD3365367T2 (ro) | Anticorpi monoclonali împotriva ploşniţelor de pat și procedee de obţinere și utilizare a acestora | |
EA201992883A1 (ru) | АНТИТЕЛА К TrkB | |
CL2014003373A1 (es) | Anticuerpos monoclonales especificos para el antígeno m del virus metapneumovirus humano (hmpv), producidos y secretados por hibridomas celulares , útiles para la deteccion y el diagnostico de la infeccion causada por hmpv. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20230605 |